The Cancer Genome Atlas (TCGA) research network has played a pivotal role in uncovering the genetic landscape of GBM, identifying mutations in genes such as EGFR, TP53, and PTEN that contribute to tumor heterogeneity (12, 13). The gene discussed is EGFR; the disease is glioblastoma.